Filters

686 Results

relevance


Lumosity

Ad Alert

Lumosity

Lumosity will pay $2 million back to customers to settle federal charges it deceived consumers with unfounded claims that its brain games could help improve mental performance.

Blossom Nature

Ad Alert

Blossom Nature

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.

Enlifta

Ad Alert

Enlifta

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.

Rite Aid

Ad Alert

Rite Aid

Drugstore chain’s No. 1 doctor-recommended claims come down in wake of NAD inquiry.

PhytoZon

Ad Alert

PhytoZon

Another cure-all supplement? NAD refers company to the FTC and FDA for further review.

Show More